PTPRC and neoplasm: Although the level of APJ expression was lower than in ECs, CD45+CD31− hematopoietic-derived tumor-associated immune cells are suggested to affect tumor progression to some extent via their cytotoxic effects (CD8+ T cells) or their immunosuppressive action (regulatory T cells).